PTM |
Post-translational modification |
HCC |
Hepatocellular carcinom |
TME |
Tumor microenvironment |
MAFLD |
Metabolic associated fatty liver |
NAFLD |
Nonalcoholic fatty liver disease |
NASH |
Nonalcoholic steatohepatitis |
CO2 |
Carbon dioxide |
TCA |
Tricarboxylic acid |
PEP |
Phosphoenolpyruvate |
LDHA |
Lactate dehydrogenase A |
GDH |
Glutamate dehydrogenase |
DC |
Dendritic cells |
MCT |
Monocarboxylate transporter |
HK |
Hexokinase |
GAPDH |
Glyceraldehyde-3-phosphate dehydrogenase |
PKM2 |
Pyruvate kinase 2 |
LDH |
Lactate dehydrogenase |
TACE |
Transarterial-chemoembolization |
GPR81 |
G protein-coupled receptor 81 |
PDK |
Pyruvate dehydrokinase |
PDH |
Pyruvate dehydrogenase |
HIF-1α |
Hypoxia-inducible factor 1α |
PCAF |
P300/CBP-associated factor |
NK |
Natural killer |
Tregs |
Regulatory T cells |
CTLs |
Cytotoxic T lymphocytes (CTLs) |
NKTs |
Natural killer T cells |
TAMs |
Tumor-associated macrophages |
VEGF |
Vascular endothelial growth factor |
ARG1 |
Arginase-1 |
MDSCs |
Myeloid-derived suppressor cells |
PHD |
Prolyl hydroxylase |
BMDM |
Bone marrow-derived macrophages |
INF-γ |
Interferon gamma |
LGSH |
Lactyl-glutathione |
GLO2 |
Glyoxalase 2 |
HDAC |
Class I histone deacetylases |
BCAP |
Phosphoinositide 3-kinase |
TIMs |
Tumor-infiltrating myeloid cells |
NSCLC |
Non-small cell lung cancer |
VHL |
Inactive von Hippel-Lindau |
ccRCC |
Clear cell renal cell carcinoma |
PDGFRβ |
Platelet-derived growth factor receptor beta |
LCSCs |
Liver cancer stem cells |
ALDOA |
Aldolase A |
LDHi |
Lactate dehydrogenase inhibitor |
NTT |
Non-tumor tissues |
PD-1 |
Programmed cell death protein-1 |
CTLA-4 |
Cytotoxic T lymphocyte antigen |
TIGIT |
T cell Ig and ITIM domain |
TIM-3 |
T cell immunoglobulin domain and mucin domain-3 |
LAG3 |
Lymphocyte activation gene 3 |
BTLA |
B and T lymphocyte attenuator |
2-DG |
2-Deoxy-D-glucose |
3-BrPA |
3-Bromopyruvate |
ESCC |
Esophageal squamous cell carcinoma |